Basic information Safety Supplier Related

7-Bromo-2-(4-hydroxyphenyl)-1,3-benzoxazol-5-ol

Basic information Safety Supplier Related

7-Bromo-2-(4-hydroxyphenyl)-1,3-benzoxazol-5-ol Basic information

Product Name:
7-Bromo-2-(4-hydroxyphenyl)-1,3-benzoxazol-5-ol
Synonyms:
  • 7-Bromo-2-(4-hydroxyphenyl)-1,3-benzoxazol-5-ol
  • WAY 200070
  • 7-bromo-2-(4-hydroxyphenyl)-5-benzoxazolol
  • WAY200070;WAY 200070
  • 5-Benzoxazolol, 7-bromo-2-(4-hydroxyphenyl)-
  • 7-Bromo-2-(4-hydroxyphenyl)benzo[d]oxazol-5-ol
  • Estrogen Receptor/ERR,WAY200070,WAY-200070,Inhibitor,inhibit
CAS:
440122-66-7
MF:
C13H8BrNO3
MW:
306.11
EINECS:
604-604-1
Mol File:
440122-66-7.mol
More
Less

7-Bromo-2-(4-hydroxyphenyl)-1,3-benzoxazol-5-ol Chemical Properties

Boiling point:
463.6±35.0 °C(Predicted)
Density 
1.720±0.06 g/cm3(Predicted)
storage temp. 
Store at RT
solubility 
DMSO: ≥20mg/mL
form 
solid
pka
7.26±0.40(Predicted)
More
Less

Safety Information

Hazard Codes 
T
Risk Statements 
25-36
Safety Statements 
26-45
RIDADR 
UN 2811 6.1 / PGIII
WGK Germany 
3
HazardClass 
6.1
More
Less

7-Bromo-2-(4-hydroxyphenyl)-1,3-benzoxazol-5-ol Usage And Synthesis

Uses

WAY 200070 is an aryl diphenolic azole and a selective ERβ agonist. This compound is suitable for estrogen receptor signaling research.

Biological Activity

WAY-200070 is a selective estrogen receptor agonist with IC50 of 2.3 nM.

in vivo

Administration of WAY-200070 (30 mg/kg sc) causes nuclear translocation of ERRβ receptors in WT mice. Administration of it produces a delayed 50% increase in dopamine in the striatum of wild type mice. It reduces immobility time in the mouse tail suspension test indicating an antidepressant-like effect. In gonadally intact male and female mice WAY-200070 increases agonistic behaviors such as pushing down and aggressive grooming, while leaving attacks unaffected. Ovariectomized (ovx) mice treated with PPT fail to learn the socially acquired preference, while WAY-200070-treated ovx mice shows a two-fold prolonged preference for the food eaten by their demonstrator. WAY-200070 , shows significantly decreased anxiety-like behaviors in both the open-field and elevated plus maze and significantly less depressive-like behaviors in the forced swim test.

< /div>

target

IC50: 2.3 nM (ERRβ), 155 nM (ERRα)

7-Bromo-2-(4-hydroxyphenyl)-1,3-benzoxazol-5-olSupplier

Tianjin Nuokang Pharmaceutical Technology Co., Ltd. Gold
Tel
022-23989838 13810451150
Email
44766350@qq.com
3B Pharmachem (Wuhan) International Co.,Ltd.
Tel
821-50328103-801 18930552037
Email
3bsc@sina.com
Wuhan Vanzpharm Inc.
Tel
027-84492310 13657243668
Email
wangting@vanzpharm.com
Jiangsu Aikon Biopharmaceutical R&D co.,Ltd.
Tel
025-66099280 17798518460
Email
cfzhang@aikonchem.com
Shanghai Lollane Biological Technology Co.,Ltd.
Tel
021-52996696,15000506266 15000506266